PDS Biotechnology Corp Cash Flow-to-Debt Ratio
PDS Biotechnology Corp cash flow-to-debt ratio. PDS Biotechnology Corp (PDSB) has a Cash Flow-to-Debt Ratio of -0.23x as of June 2026, meaning its operating cash flow of $-2.79 Million could theoretically repay 0% of its total liabilities ($12.39 Million) in one year. Check PDS Biotechnology Corp (PDSB) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of PDS Biotechnology Corp (2012–2025)
Cash flow-to-debt ratio of PDS Biotechnology Corp from 2012 to 2025. Historical debt coverage capacity for PDS Biotechnology Corp across 14 annual periods. Check PDSB capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
PDS Biotechnology Corp Cash Flow-to-Debt Ratio by Year (2012–2025)
PDS Biotechnology Corp cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for PDS Biotechnology Corp. For the full cash flow conversion analysis, see PDS Biotechnology Corp cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.31x | $-27.75 Million | $21.24 Million | ▲ +1.7% |
| 2024 | -1.33x | $-35.03 Million | $26.35 Million | ▼ -31.4% |
| 2023 | -1.01x | $-33.64 Million | $33.26 Million | ▼ -29.8% |
| 2022 | -0.78x | $-25.71 Million | $33.01 Million | ▲ +75.1% |
| 2021 | -3.13x | $-12.49 Million | $3.99 Million | ▲ +10.4% |
| 2020 | -3.50x | $-13.15 Million | $3.76 Million | ▲ +46.0% |
| 2019 | -6.47x | $-18.07 Million | $2.79 Million | ▼ -24.5% |
| 2018 | -5.19x | $-33.15 Million | $6.38 Million | ▼ -286.1% |
| 2017 | -1.35x | $-40.70 Million | $30.25 Million | ▲ +9.6% |
| 2016 | -1.49x | $-32.19 Million | $21.64 Million | ▲ +20.6% |
| 2015 | -1.87x | $-21.75 Million | $11.62 Million | ▼ -765.2% |
| 2014 | -0.22x | $-9.71 Million | $44.88 Million | ▲ +35.2% |
| 2013 | -0.33x | $-8.04 Million | $24.08 Million | ▲ +47.2% |
| 2012 | -0.63x | $-2.25 Million | $3.55 Million | — |